Private Advisor Group LLC Purchases New Stake in DaVita Inc. (NYSE:DVA)

Private Advisor Group LLC bought a new position in shares of DaVita Inc. (NYSE:DVA) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 4,285 shares of the company’s stock, valued at approximately $348,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Parkside Financial Bank & Trust increased its stake in DaVita by 88.6% during the first quarter. Parkside Financial Bank & Trust now owns 313 shares of the company’s stock worth $35,000 after acquiring an additional 147 shares during the last quarter. Sentry Investment Management LLC increased its stake in DaVita by 63.4% during the fourth quarter. Sentry Investment Management LLC now owns 371 shares of the company’s stock worth $28,000 after acquiring an additional 144 shares during the last quarter. Bessemer Group Inc. increased its stake in DaVita by 55.1% during the first quarter. Bessemer Group Inc. now owns 445 shares of the company’s stock worth $36,000 after acquiring an additional 158 shares during the last quarter. AlphaMark Advisors LLC increased its stake in DaVita by 66.0% during the first quarter. AlphaMark Advisors LLC now owns 528 shares of the company’s stock worth $43,000 after acquiring an additional 210 shares during the last quarter. Finally, CWM LLC increased its stake in DaVita by 78.1% during the first quarter. CWM LLC now owns 830 shares of the company’s stock worth $67,000 after acquiring an additional 364 shares during the last quarter. Institutional investors and hedge funds own 84.69% of the company’s stock.

DaVita Stock Up 0.6 %

DaVita stock opened at $102.99 on Tuesday. DaVita Inc. has a 1-year low of $65.28 and a 1-year high of $116.97. The company has a debt-to-equity ratio of 7.13, a current ratio of 1.25 and a quick ratio of 1.20. The stock has a market cap of $9.40 billion, a PE ratio of 20.48, a P/E/G ratio of 1.13 and a beta of 0.94. The stock’s fifty day moving average is $103.04 and its two-hundred day moving average is $93.19.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $2.08 earnings per share for the quarter, beating analysts’ consensus estimates of $1.66 by $0.42. DaVita had a return on equity of 60.67% and a net margin of 3.98%. The company had revenue of $3 billion for the quarter, compared to analysts’ expectations of $2.95 billion. During the same period last year, the firm earned $2.30 earnings per share. DaVita’s quarterly revenue was up 2.5% on a year-over-year basis. On average, sell-side analysts expect that DaVita Inc. will post 7.22 EPS for the current fiscal year.

Insider Transactions at DaVita

In other news, insider Kathleen Alyce Waters sold 9,794 shares of DaVita stock in a transaction dated Tuesday, August 22nd. The stock was sold at an average price of $101.81, for a total transaction of $997,127.14. Following the sale, the insider now owns 81,297 shares in the company, valued at $8,276,847.57. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.40% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on DVA. Truist Financial raised their price target on DaVita from $100.00 to $115.00 and gave the stock a “hold” rating in a research report on Thursday, July 13th. Sanford C. Bernstein lifted their target price on DaVita from $88.00 to $100.00 in a report on Monday, May 15th. TheStreet upgraded DaVita from a “c” rating to a “b-” rating in a report on Monday, May 8th. UBS Group upgraded DaVita from a “neutral” rating to a “buy” rating and lifted their target price for the company from $100.00 to $142.00 in a report on Monday, August 7th. Finally, Bank of America lifted their target price on DaVita from $86.00 to $96.00 in a report on Tuesday, May 9th. Four equities research analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $105.29.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.